The growing epidemic of hypertension among children and adolescents: A challenging road ahead

Pediatric Cardiology

Volumn 33, Issue 7, 2012, Pages 1013-1020

  Assadi, Farahnak ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Cardiovascular events; Children and adolescents; Chronic kidney disease; Epidemic; Hypertension; Team approach

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE CONTROL; HEALTH CARE PERSONNEL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MICROALBUMINURIA; OBESITY; OUTCOME ASSESSMENT; PATIENT CARE; PREHYPERTENSION; PROTEIN BLOOD LEVEL; REVIEW; TOTAL QUALITY MANAGEMENT;

EID: 84867872840     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0333-5     Document Type: Review

References (36)

1. Agrawal R, Bunaye Z, Beker DM (2008) Prognostic significance of between arm blood pressure differences. Hypertension 51:657-662
2. Amin AP, Salisbury AC, McCullough PA, Gosch K, Spertus JA, Venkitachalam L et al (2012) Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med 172:246-253
3. Assadi F (2002) Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 17:107-110
4. Assadi F (2007) Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol 28:27-33
5. Assadi F (2008) Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol 29:580-584
6. Bianchi S, Bigazzi R, Campese VM (1999) Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 34:973-995
7. Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51:1403-1419
8. Chobanian AV, Bakris GL, Black HR, Cushman WC (2003) The 7th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 Report. JAMA 289:2560
9. Cutler DM, Everett W (2010) Thinking outside the pillboxmedication adherence as a priority for health care reform. N Engl J Med 362:1553-1555
10. Daniels SR, Loggia JM, Hoary P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907-1911
11. Falkner B, Kushner H, Onesti G, Angelakos ET (1981) Cardiovascular characteristics in adolescents who develop essential hypertension. Acta Paediatr 3:521-527
12. Flynn JT, Newburger JW, Daniels SR (2004) A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr 145:353-539
13. Fonarow G, O'Neill W (2012) Blood pressure differences between arms could signal heart risk. 30 January 2012; Lancet online edition 4:24
14. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN et al (2008) Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 168:1159-1164
15. Graves JW, Althaf MM (2006) Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol 21:1640-1652
16. Greenlund KJ, Croft JB, Mensah GA (2004) Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 164:2113-2118
17. Hansen ML, Gunn PW, Kaelber DC (2007) Underdiagnosis of hypertension in children and adolescents. JAMA 298:874-879
18. Hilgers KF, Dotsch J, Rascher W, Mann JF (2004) Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol 19:956-961
19. James P, Oparil S, Carter BL, et al (2012) The Eighth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 8 (in press). Retrieved at http://www.nhlbi.nih.gov/ guidelines/hypertension/jnc8/index.htm
20. Lauer RM, Clarke WR (1989) Childhood risk factors for high adult blood pressure: the Muscatine study. Pediatrics 84:633-641
21. Litwin M, Niemirska A, Ruzicka M, Febber J (2009) White-coat hypertension in children: not rare and not benign? J Am Soc Hypertens 3:416-423
22. McCambridge TM, Benjamin HJ, Brenner JS et al (2010) Athletic participation by children and adolescents who have systemic hypertension. Council on sports and fitness. Pediatrics 125:1287-1294
23. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
24. Ogden CL, Carroll MD, Kit BK, Flegal KM (2012) Prevalence of obesity and trends in body mass index among U.S. children and adolescents, 1999-2010. JAMA 307:483-490
25. Ohkubo T, Kikuya M, Asayama K, Obara T, Hara A et al (2006) Prognostic significance of nighttime, early morning, and daytime blood pressures on the risk of cerebrovascular and cardiovascular mortality: the Ohasama Study. J Hypertens 24:1841-1844
26. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487
27. Pimenta E, Calhoun DA (2007) Resistant hypertension and aldosteronism. Curr Hypertens Rep 29:353-359
28. Sakarcan A, Tenney F, Wilson JT et al (2001) The pharmacokinetics of irbesartan in hypertensive children and adolescents. J Clin Pharmacol 41:742-749
29. Sica DOA, White W (1999) Chronotherapeutics and its role in the treatment of hypertension and cardiovascular disease. Am J Hypertens 12:159-165
30. Sorof J, Daniels SR (2002) Obesity hypertension in children: a problem of epidemic proportions. Hypertension 40:44-447
31. Sorof JM, Cargo P, Graepel J (2002) Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol 17:345-350
32. Soffer B, Zhang Z, Miller K (2003) A double-blind, placebocontrolled, dose-response study of the effectiveness and safety of linsinopril for children with hypertension. Am J Hypertens 16:795-800
33. Tirosh A, Afek A, Rudich A et al (2010) Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension 56:203-209
34. Walsh JM, McDonald KM, Shojania KG, Sundaram V, Nayak S, Lewis R et al (2006) Quality improvement strategies for hypertension management: a systematic review. Med Care 44:646
35. Wells T, Frame V, Soffer B et al (2002) A double-blind, placebocontrolled, dose-response study of the effectiveness of enalepril for children with hypertension. J Clin Pharmacol 42(8):870-880
36. The ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288:2981-2997